Characterization of apolipoprotein L1 variant-overexpressing cell lines for high-throughput drug screening01/01/2023 - 12/31/2024 (Multi-PI)
PI:
Nader Rahimi, PhDPreeclampsia Foundation
IGPR-1 in Colon Cancer Chemotherapy06/19/2015 - 05/31/2017 (PI)
NIH/National Cancer Institute5R21CA193958-02
Overcoming resistance to anti-angiogenesis therapy12/08/2014 - 11/30/2016 (PI)
NIH/National Cancer Institute5R21CA191970-02
VEGFR - 1 and VEGFR - 2 in Angiogenesis04/01/2002 - 02/29/2008 (PI)
NIH/National Eye Institute5 R01 EY12997 05
Anti-Angiogenic Signaling Molecules in Retinal Cells02/01/2002 - 01/31/2005 (PI)
NIH/National Eye Institute5 R03 EY13706 03
Study of VEGFR-1 and VEGFR-2 in Angiogenesis01/01/2001 - 12/31/2004 (PI)
Research to Prevent Blindness
Signal Transduction by VEGF Receptor -2 During Angiogenesis11/01/1999 - 10/30/2000 (PI)
American Cancer Society